BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Immunology and inflammation

  July 25, 2024
• Nevada

  July 25, 2024
• 

  Promotions

  Not Getting Promoted at Work? Here’s What You Should Do

  When you don’t get the promotion you wanted, it’s important to assess your company and yourself so you can improve your odds in the future.

  July 25, 2024

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Job Trends

  Majority Considering Jobs Outside Biopharma, BioSpace Report Finds

  Employed and unemployed biotech and pharma professionals are thinking about job hunting in other fields amidst a challenging labor market.

  July 25, 2024

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Earnings

  AstraZeneca, Roche, Sanofi Raise 2024 Outlooks on Strong Q2 Sales

  The three companies raised their respective full-year earnings forecasts on Thursday, buoyed by robust sales in the second quarter and their continued dominant market positions.

  July 25, 2024

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Regulatory

  FDA Issues Final Guidance for Using Real-World Data in Drug Applications

  The regulator on Wednesday provided recommendations to drugmakers for assessing the use of electronic health records and medical claims data to support their applications.

  July 25, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Career Advice

  7 Companies Hiring Automation Engineers

  Looking for an automation engineer job? Check out these seven companies hiring life sciences professionals like you.

  July 25, 2024

   · 

  1 min read

   · 

  Angela Gabriel
• 

  GLP-1

  Viking Takes Obesity Candidate into Phase III to Rival Lilly, Novo

  With promising Phase II data in hand, Viking Therapeutics is pushing its subcutaneous GLP-1/GIP receptor dual agonist into late-stage development, the company announced on Wednesday.

  July 25, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Earnings

  Despite Near 30% Drop in Humira Sales, AbbVie Beats Wall Street’s Q2 Revenue Expectations
  

  While Humira sales were impacted by cheaper biosimilars, AbbVie reported in its second-quarter earnings results Thursday that revenues jumped nearly 45% for Skyrizi and almost 56% for Rinvoq year over year, respectively.

  July 25, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Collaboration

  Novartis, Dren Bio Ink Potential $3B Deal for Anti-Myeloid Bispecific Antibodies for Cancer

  Novartis continues its dealmaking spree with a bet on Dren Bio’s Targeted Myeloid Engager and Phagocytosis platform to develop bispecific antibodies in oncology.

  July 25, 2024

   · 

  2 min read

   · 

  Tristan Manalac